3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Small Cell Lung Carcinoma
11
Fallopian Tube Neoplasms
9
Neuroblastoma
6
Neoplasm Metastasis
3
Lung Neoplasms
3
Ganglioneuroblastoma
3
Carcinoma, Ovarian Epithelial
3
Uterine Cervical Neoplasms
2
Sarcoma, Ewing
2
Rhabdoid Tumor
2
Recurrence
2
Leukemia, Myeloid, Acute
2
Glioma
2
Central Nervous System Neoplasms
2
Wilms Tumor
1
Thrombocythemia, Essential
1
SCLC
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pleuropulmonary blastoma
1
Peritoneal Neoplasms
1
Pediatric Brain Tumor
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Interventions
Cyclophosphamide
5
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Biopsy
4
Nivolumab
3
sodium-iodide symporter
2
fludarabine
2
cemiplimab
2
X-Rays
2
Whole-Body Irradiation
2
Stem Cell Transplantation
2
Photons
2
Mycophenolic Acid
2
Immunoglobulin G
2
Disulfides
2
Cyclosporine
2
10-propargyl-10-deazaaminopterin
2
treosulfan
1
talimogene laherparepvec
1
sargramostim
1
ruxolitinib
1
pembrolizumab
1
fludarabine phosphate
1
entrectinib
1
duvelisib
1
ceritinib
1
belinostat
1
alectinib
1
Vincristine
1
Vinblastine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large-Cell, Anaplastic
×
Topotecan
×
90 days
×
Clear all
No trials found.